Clinical Trial Update: Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL) [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluating intravenous vitamin C in patients with refractory non-Hodgkin lymphoma was terminated; results were posted in December 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Non-Hodgkin Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2014-12-10